Cipla to sell animal health biz

PTI New Delhi | Updated on January 13, 2018 Published on March 05, 2017

Pharma firm Cipla today said it plans to sell its animal health business in South Africa and sub-Saharan Africa for about ₹191 crore.

The company has entered into agreements through its wholly owned subsidiary Inyanga Trading 386 Proprietary with the group companies of Ascendis Health, Cipla said in a statement.

Under the agreements, Cipla will divest its 100 per cent stake in Cipla Agrimed Proprietary South Africa and Cipla Vet Proprietary, South Africa, it said. The deal is subject to customary closing conditions, including approval from competition commission of South Africa and is expected to close in the next three months, it said.

Follow us on Telegram, Facebook, Twitter, Instagram, YouTube and Linkedin. You can also download our Android App or IOS App.

Published on March 05, 2017
This article is closed for comments.
Please Email the Editor